Cite
HARVARD Citation
Parasrampuria, R. et al. (2019). A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants. Clinical pharmacology in drug development. 8 (5), pp. 674-681. [Online].